Fig. 6From: An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis(A) The estimated major pathologic regression (MPR) rate of patients circulating tumor DNA (ctDNA) changed positive to negative; (B) The estimated MPR rate of patients ctDNA kept negative from beginning to endBack to article page